UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF...
As Filed with the Securities and Exchange Commission on January 13, 2011 Registration No. 333-161264 Registration...
Ramius and Royalty Pharma Announce Successful Conclusion of Cypress Bioscience Tender Offer PR Newswire SAN DIEGO and NEW YORK, Jan. 6, 2011 SAN...
SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT...
SAN DIEGO, CA and NEW YORK, NY -- (Marketwire) -- 01/04/11 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) ("Cypress"), a pharmaceutical company...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.